The Business Times
SUBSCRIBERS

New genetic test to detect cancer in healthy people

Pathway's screening represents a first in 'liquid biopsy' testing

Published Thu, Sep 10, 2015 · 09:50 PM
Share this article.

Chicago

PATHWAY Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, was to launch on Thursday a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.

The test represents a first in the rapidly developing field of "liquid biopsies", which use gene sequencing technology to screen blood samples to trace amounts of DNA associated with different cancers.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Technology

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here